SCIENCE OF
POSSIBILITY
At Vertex, we invest in scientific innovation to create transformative medicines for people with serious diseases.
We are presenting new data on our cystic fibrosis medicines at the 2024 North American Cystic Fibrosis Conference
We've announced the acceptance of the New Drug Application submission to the FDA for our investigational acute pain medication
Vertex reports second quarter 2024 financial results
Vertex announces the FDA has accepted the application and granted Priority Review for our fifth investigational CFTR modulator
We presented new data at the 2024 American Diabetes Association Scientific Sessions on our investigational program for type 1 diabetes
Working at Vertex
Our company is built on an inclusive culture that brings together the best and brightest in every field striving for one goal: to improve the lives of people with serious diseases.
Find a Vertex clinical trial
Volunteers who participate in clinical trials
help make new medicines a reality.
Featured stories
Vertex is committed to working alongside the CF community on this journey to support those living with CF.
Learn how we support independent research in cystic fibrosis (CF) through our Vertex CF Research Innovation Awards and Vertex Innovation Awards programs.
Our commitment to the sickle cell community extends beyond our research. Learn how we’ve worked with Sickle Cell Warriors to amplify their voices and experiences, highlighting the multifaceted nature of this disease.
Vertex is committed to working alongside the CF community on this journey to support those living with CF.
Learn how we support independent research in cystic fibrosis (CF) through our Vertex CF Research Innovation Awards and Vertex Innovation Awards programs.
Our commitment to the sickle cell community extends beyond our research. Learn how we’ve worked with Sickle Cell Warriors to amplify their voices and experiences, highlighting the multifaceted nature of this disease.
